AtriCure today announced the first use of its newest AtriClip device for minimally invasive concomitant procedures.

AtriCure, Inc. is headquartered in Mason, OH. The company is focused on developing, making, and distributing devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage ...

Across the recent three months, 11 analysts have shared their insights on AtriCure ATRC, expressing a variety of opinions spanning from bullish to bearish. The table below summarizes their recent ...

MASON, Ohio, April 10, 2025--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA ...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management ...

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management ...